| Prev Close | 21.36 |
| Day Low/High | 20.80 / 21.60 |
| 52 Wk Low/High | 19.25 / 24.00 |
Enact Holdings Inc (ACT)
21.17
| Exchange | |
| Shares Outstanding | 162.84B |
| Market Cap | 3.48B |
| Div & Yield | N.A. (N.A) |
Latest News
What Bill Ackman's Voice Could Mean for the Valeant Board Room
Billionaire Bill Ackman's recent appointment to the troubled drugmaker's board could signal a meanful change of direction.
Jim Cramer: There’s No Way We’ll See More Railroad M&A
Jim Cramer says the antitrust environment out there will make it difficult for any railroad mergers to be approved by regulators.
Federal Reserve to Reassess Global Risks in Minutes on Wednesday
Investors are gearing up for another assessment of the global economy, as the Fed Prepares to release the minutes of its March meeting.
Jim Cramer: The Allergan-Pfizer Deal Is Absolutely Dead
Jim Cramer says the merger between Pfizer and Allergan isn't going anywhere, as lawmakers try to limit corporate inversions.
Jim Cramer: Valeant Needs a Government Monitor
TheStreet's Jim Cramer said Valeant Pharmaceuticals' (VRX) move to appoint billionaire investor Bill Ackman to the board of directors isn't enough and a government monitor is needed.
We're Feeling Better About Growth Stocks
Amazon is among the indicators.
New Greek Plans 'Going in the Right Direction' Says EU Official
And four other things you need to know now.
Failed Greece Negotiations Hit Futures; Dollar Worries Persist
But investors are likely to be wary ahead of the Fed meeting.
Jim Cramer Says Own Ebay as a Way to Play Its Split with Paypal
TheStreet’s Jim Cramer answers your Twitter questions from the floor of the New York Stock Exchange.
Health Care Mergers Are Just Getting Started
Deals coming fast and furious in the best group in town.
Deluge of Deals Isn't About to Dry Up
Acquisitions cut into overabundance of companies.
We're Not Done Talking Deals
Don't get me started ... wait, DO get me started.
Plug Power, Actavis, Rosetta Bright Spots in Flat Midday Trading
Stocks hovered around the flat line in midday trading Monday with the Dow and the S&P 500 slightly down and the Nasdaq inching slightly higher.
Day Ahead: China and Greece
China cut rates again but all eyes are now on Greece.
China Cuts Rates Again; Will It Work?
Cramer says it can't stay 'moribund that much longer.'
Shake Shack Earnings, Retail Sales: What to Watch in the Week Ahead
For the week of May 11 we await results from Actavis (ACT), Sotheby's (BID), GoDaddy (GDDY), Cisco Systems (CSCO), Macy's (M), Shake Shack (SHAK), Applied Materials (AMAT), and Petrobras (PBR).
People Are in a Rush to Get Out
Days like this can be very dispiriting.
Stocks to Buy in a Sea Change
Here's what stocks would do well with a strong dollar.
A Difficult Market Juncture
How do people get back into domestic stocks if there's no hook?
Ringing the Register Won't Help
Rotation is just starting and can't be turned quickly.
Earnings and Marriage Season
Biotech companies are saying, "I do."
Deal or No Deal, Stick With Mylan
Teva bid highlights M&A action in health care sector.
Deal or No Deal, Stick With Mylan
Teva bid highlights M&A action in health care sector.
Say It With Me: Specialty Pharma
These companies are the hottest thing going.
Mylan Deal Is All That Shell Is Not
The ecstasy and the agony of M&A all in one day.
Enough Already About the Fed
There are much more important things going on.
What Stocks to Buy Now
There are dozens of juicy opportunities in this market.